Olexa, Peter
3 papers on CoChatORCID 0000-0002-1846-4554
Most cited papers
- Verified
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
Schwartz, G. G., Szarek, M., Bittner, V. A., Diaz, R., Goodman, S. G., Jukema, J. W., Landmesser, U., López-Jaramillo, P., Manvelian, G., Pordy, R., et al. (2021) · Journal of the American College of Cardiology
Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research
Cited by 150
- Verified
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Hagström, E., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Danchin, N., Diaz, R., Goodman, S. G., Harrington, R. A., Jukema, J. W., et al. (2022) · Circulation
Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research
Cited by 118
- Verified
Effect of dapagliflozin in DAPA-HF according to background glucose-lowering therapy
Docherty, K. F., Jhund, P. S., Bengtsson, O., DeMets, D. L., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Langkilde, A. M., Martinez, F. A., Sabatine, M. S., et al. (2020) · Diabetes Care
Diabetes Treatment and ManagementHeart Failure Treatment and Management
Cited by 44
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free